MDEA 2014 Finalists: Drug-Delivery Devices and Combination Products

MDEA 2014 Finalists: Drug-Delivery Devices and Combination Products

Drug-Delivery Devices and Combination Products 


Auvi-Q | Debioject | FOX Handheld Nebulizer | MedCenter | PROPEL


Auvi-Q epinephrine auto-injector. Manufactured by Sanofi (Bridgewater, NJ). Entry submitted by Kaléo Pharma (Richmond, VA). Auvi-Q is a single-use epinephrine autoinjector used to treat life-threatening allergic reactions (anaphylaxis). It is the size and shape of a credit card, the thickness of a cell phone, and includes a unique voice instruction system. Supply and design credit to Kaléo Pharma (Richmond, VA) and Medivative Technologies (Indianapolis). 



DebioJect intradermal drug-delivery device. Manufactured and submitted by Debiotech SA (Lausanne, Switzerland). The DebioJect was conceived to overcome the problems encountered with classical intradermal delivery techniques. The innovative microneedle allows both pain-free and precise injection of up to 500 μL in a few seconds. Supply and design credit to CEA-LETI (Grenoble, France), Mecaplast SA (Botterens, Switzerland), and the Royal Institute of Technology (KTH) (Stockholm, Sweden).


FOX Handheld Nebulizer. Manufactured by and submitted by Vectura GmbH (Germany). The FOX inhaler is a fast and efficient handheld nebulizer for treatment of respiratory diseases. Its breathing control enables highly accurate drug delivery to the small airways, ensuring optimal therapeutic results of the inhaled liquid medications. Supply and design credit to Ian Mahaffy Industrial Design Ltd. (London, UK).




MedCenter pharmacy kiosk. Manufactured and submitted by MedAvail Technologies Inc. (Mississauga, Canada). The MedAvail MedCenter enables a remote pharmacist in a call center to provide confidential, real-time professional advice and verify the automated dispense of prescription medications to patients at the kiosk. Supply and design credit to Squint Innovation & Branding Inc. (Toronto, Canada).


PROPEL mometasone furoate implant and PROPEL mini mometasone furoate implant. Manufactured and submitted by Intersect ENT (Menlo Park, CA). PROPEL and PROPEL mini dissolvable steroid-releasing implants reduce the need for additional surgical procedures and for oral steroids, which can have serious side effects, for patients suffering from chronic sinusitis.
Dental Instruments, Equipment, and SuppliesGeneral Hospital and Therapeutic Devices


Filed Under
500 characters remaining